Implanted continuous glucose sensor proven safe and accurate in types 1 and 2 diabetes

(Mary Ann Liebert, Inc./Genetic Engineering News) Results of the PRECISE II study showed the implanted continuous glucose monitoring (CGM) system from Eversense to be safe and highly accurate over the 90-day sensor life in patients with type 1 or type 2 diabetes.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news